Hyris is an innovation-based, fast-growing biotech Company, which aims to
democratize genetic analysis by offering
its partners and clients a disruptive System which enables genetic testing of
biological samples in any setting, at any time.
When diagnostic and genetic analysis must be performed under the harshest
conditions, Hyris checks all the boxes.

Pi Campus

Astanor Ventures

Hyris

Hyris supports researchers and developers to launch testing kits via its new Onboarding Programs, leveraging its disruptive AI platform.            
 
Developing and onboarding genetic tests has always been challenging, from staffing and integrating competencies to securing research funding and ensuring sufficient testing volumes; adapting to the various compliance environments, meeting the requirements for molecular assays, and preparing the necessary documentation for market launch can all pose additional risks. 
Technological access gaps remain a major obstacle in the development of new solutions across various industries. Hyris aims to change this by utilizing the advanced AI capabilities of its genetic testing platform, which is well-known for its portability, accessibility, and versatility.

To further speed up the Go-to-market of new tests, Hyris remains committed to its goal of making genetics and health insights accessible to everyone and is taking a new step in its partnership approach. By offering proper education and advanced technical assistance, Hyris’ innovative Onboarding Programs are specifically designed to provide further support to researchers and kit developers at every stage of the process of research and development of diagnostic tests.

Such is the case of Luminis Water Technologies , a leader in microbiome profiling and treatment solutions, which embraced Hyris’ Program to bring on-site qPCR diagnostics to the aquaculture industry, enabling customers to quickly and accurately test for pathogens, viruses, and bacteria, ultimately improving their operations' overall safety and productivity in such industry. Luminis adopted the Hyris system to develop new qPCR diagnostics kits, enabling its customers to perform genetic analysis on-site rather than sending samples to a lab, significantly reducing turnaround time and allowing for more informed decision-making. Additionally, on-site testing eliminates the need for expensive lab equipment, and operators can now perform testing with minimal training.

The new Onboarding Programs are contributing to making Hyris the first choice for testing labs, test developers, and researchers looking to bring on specific tests involving smaller sample arrays, reduced time to results, and increased efficiencies and profitability. 

Hyris keeps true to its vision: to democratize genetics and health insights.

Read the whole article:
https://lnkd.in/dWuvgk9j


Hyris’ unique path brings biotechnologies toward new horizons, combining the potential of a truly connected IoT infrastructure with the Artificial Intelligence embedded into its cloud-software platform, to allow all users new dimensions for the analysis of real-world data and diagnostic trends. 

From Botanicals to Nutraceuticals, from Human Diagnostics to Animal Health, Hyris has been expanding in different industries, providing cutting-edge solutions wherever health is at risk.

Discover more at www.hyris.net
and feel confident to contact an Hyris expert to help you move beyond your current capabilities.

#hyris #hyrissystem #artificialintelligence #iot #innovation 

Domain Not Resolving

Euro

HSTS

DNSSEC

Cloudflare CDN

Cloudflare

Google Analytics 4

Cloudflare Network Error Logging

Apple Mobile Web App Capable

Apple Mobile Web App Status Bar Style

Executive Vice President - Hyris Americas

Fergal O'Moore

Chargé De Production

Alexandre Perez

Vice-Président en Charge Du Parc Matériel

Antoine Pelerin

Business Management

David Ayris

Vice President en Charge De l'Événementiel

Maxime Leboeuf

Vice Président en Charge Du Matériel

Tanguy Mondet

Stefano Lo Priore

Co-Founder, Chief Executive Officer & Managing Director

Alberto Amati

Co-Founder

Europe, Middle East, and Africa (EMEA) Early Stage Companies With More Than $1M in Revenue

England Companies With More Than $1M in Revenue (Top 10K)

London Biotechnology Companies

London Early Stage Companies With Less Than $50M in Revenue

Hyris offers its partners and clients a disruptive platform that enables genetic testing of biological samples in any setting, at any time, with real time access to results on its dedicated cloud based software platform.

Series A - Hyris

London

England

United Kingdom

Europe

Hyris Technology Supports the Fight Against One of the World’s Deadliest Diseases, Malaria

Ulysses Biomed, binding agreement to purchase 100 percent of Hyris

Hyris Supports Researchers and Developers to Launch Testing Kits via New Onboarding Programs

Detector for measuring fluorescence in a liquid sample

A New T-Cell activation assay based on Hyris qPCR Technology marks a disruptive approach for the detection of SARS-CoV-2 specific cellular immunity

Seeking to save olive oil’s virginity or sleuth for horse meat, Europe’s Hyris and SwissDeCode gain funding

A platform for genetic testing of biological samples, usable in various settings and designed for a wide range of applications.

A marketplace for genetic testing, facilitating access to an open ecosystem for kit developers and users.

Solutions aimed at enhancing diagnostic capabilities beyond traditional laboratory settings.

Solutions designed to improve the quality of production processes in the agrifood and nutraceutical sectors.

Tools and opportunities for kit developers to reach new customers and monitor field performance.

Poland

France

HTML5

Bootstrap

Google Tag Manager

F5 NGINX

Comodo PositiveSSL Certificates

Microsoft Outlook

Vimeo

Google Fonts

Google Analytics

Amazon Route 53

Provider of genetic testing and diagnostics solutions for healthcare professionals and laboratories

Everything Genetic Ltd

Company specializing in genetic testing and health insights

Myogenes

Provider of genetic testing and diagnostics services

Igenomix Co, UK

Provider of innovative genetic testing solutions

Biomeme

Company offering molecular diagnostic testing systems

Cepheid

Provider of a wide range of products for the life science research and clinical diagnostics markets

Bio-Rad Laboratories

Hyris is a company that provides proprietary technology for testing biological samples in any setting, at any time. They offer the first marketplace for genetic testing, enabling access to an open ecosystem. Their solutions cater to healthcare & diagnostics, agrifood & environment, and kit developers.

news impact assignment basic	general	Feb 20, 2024 12:29 PM	67525c81
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Feb 20, 2024 12:29 PM	3095932d
company summary	general
signals	general
crunchbase trigger	general	Dec 4, 2024 8:54 AM	1f70033a
crunchbase profile	general	Dec 4, 2024 12:44 PM	a457c1ef
li profile	general	Feb 20, 2024 12:29 PM	6f65a2e4
translate crunchbase fundingrounds	general	Dec 4, 2024 1:38 PM	fee4547c
peers	general	Feb 20, 2024 12:29 PM	fca6c56b
news basic	general	Feb 20, 2024 12:29 PM	d87da0ba
bundesanzeiger	filings
financials download nd	financials
private financials	financials

NET:HYRIS

Hyris